BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11565769)

  • 1. Follicular neoplasms of the thyroid: predictors of malignancy?
    Zdon MJ; Fredland AJ; Zaret PH
    Am Surg; 2001 Sep; 67(9):880-4. PubMed ID: 11565769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
    Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can fine-needle aspiration biopsy of thyroid nodule help in determining the extent of surgery in follicular and Hurthle cell neoplasm at a community teaching institution?
    Hawasli A; Rizzo P; Khoury H; McCaffrey JL
    Am Surg; 2002 Oct; 68(10):907-10. PubMed ID: 12412723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cyto-histological correlation of malignant thyroid nodules: clinical factors as predictors of malignancy].
    Allen M; Sapinho I; Raposo L; Torrinha J
    Acta Med Port; 2008; 21(2):135-40. PubMed ID: 18625092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Completion thyroidectomy in patients with thyroid cancer who initially underwent unilateral operation.
    Kim ES; Kim TY; Koh JM; Kim YI; Hong SJ; Kim WB; Shong YK
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):145-8. PubMed ID: 15212657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy?
    Giorgadze T; Rossi ED; Fadda G; Gupta PK; Livolsi VA; Baloch Z
    Diagn Cytopathol; 2004 Nov; 31(5):307-12. PubMed ID: 15468114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follicular or Hürthle cell neoplasm of the thyroid: can clinical factors be used to predict carcinoma and determine extent of thyroidectomy?
    McHenry CR; Thomas SR; Slusarczyk SJ; Khiyami A
    Surgery; 1999 Oct; 126(4):798-802; discussion 802-4. PubMed ID: 10520931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unilateral lobectomy for Hurthle cell adenoma.
    Wasvary H; Czako P; Poulik J; Lucas R
    Am Surg; 1998 Aug; 64(8):729-32; discussion 732-3. PubMed ID: 9697901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
    Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
    Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hürthle cell tumors: a twenty-five-year experience.
    Arganini M; Behar R; Wu TC; Straus F; McCormick M; DeGroot LJ; Kaplan EL
    Surgery; 1986 Dec; 100(6):1108-15. PubMed ID: 3787466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body mass index in the evaluation of thyroid cancer risk.
    Mijović T; How J; Pakdaman M; Rochon L; Gologan O; Hier MP; Black MJ; Young J; Tamilia M; Payne RJ
    Thyroid; 2009 May; 19(5):467-72. PubMed ID: 19415996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of malignancy within cytologically indeterminate thyroid nodules.
    Miller B; Burkey S; Lindberg G; Snyder WH; Nwariaku FE
    Am J Surg; 2004 Nov; 188(5):459-62. PubMed ID: 15546550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is nodule size an independent predictor of thyroid malignancy?
    McHenry CR; Huh ES; Machekano RN
    Surgery; 2008 Dec; 144(6):1062-8; discussion 1068-9. PubMed ID: 19041019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of malignancy in patients with a thyroid nodule that contains Hürthle cells.
    Turanli S; Pirhan Y; Ozcelik CK; Cetin A
    Otolaryngol Head Neck Surg; 2011 Apr; 144(4):514-7. PubMed ID: 21493226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid neoplasms after therapeutic radiation for malignancies during childhood or adolescence.
    Acharya S; Sarafoglou K; LaQuaglia M; Lindsley S; Gerald W; Wollner N; Tan C; Sklar C
    Cancer; 2003 May; 97(10):2397-403. PubMed ID: 12733137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nondiagnostic thyroid fine needle aspiration cytology: outcome in surgical treatment.
    Tamez-Pérez HE; Gutiérrez-Hermosillo H; Forsbach-Sánchez G; Gómez-de Ossio MD; González-González G; Guzmán-López S; Tamez-Peña AL; Mora-Torres NE; González-Murillo EA
    Rev Invest Clin; 2007; 59(3):180-3. PubMed ID: 17910409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hurthle cell tumor.
    Chen HY; Benjamin LB; Chen MF
    Int Surg; 1996; 81(2):168-70. PubMed ID: 8912085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations for the management of cystic thyroid nodules.
    Choi KU; Kim JY; Park DY; Lee CH; Sol MY; Han KT; Kim YG
    ANZ J Surg; 2005 Jul; 75(7):537-41. PubMed ID: 15972041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hürthle cell lesions in thyroid neoplasms.
    Khan MS; al-Manee MS; Huzaimeh IA; Ahmad MS
    Int Surg; 1989; 74(4):261-6. PubMed ID: 2625402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hürthle cell tumors of the thyroid gland.
    Heppe H; Armin A; Calandra DB; Lawrence AM; Paloyan E
    Surgery; 1985 Dec; 98(6):1162-5. PubMed ID: 4071391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.